Contact Hours: 3.5

Max CEU Credits: 0.35

Learning Objectives:

Upon completion of the chapter, the reader will be able to:
1. Identify risk factors and signs and symptoms of deep vein thrombosis and pulmonary embolism.
2. Describe the processes of hemostasis and thrombosis, including the role of the vascular endothelium, platelets, coagulation cascade, and thrombolytic proteins.
3. Determine a patient’s relative risk (low, moderate, high, or very high) of developing venous thrombosis.
4. State at least two potential advantages of the low-molecular-weight heparins and fondaparinux over unfractionated heparin.
5. Formulate an appropriate prevention strategy for a patient at risk for deep vein thrombosis
6. Identify factors that place a patient at high risk of bleeding while receiving antithrombotic drugs.
7. Select and interpret laboratory test(s) to monitor antithrombotic drugs.
8. Identify and analyze warfarin drug-drug and drug-food interactions.
9. Manage a patient with an elevated International Normalized Ratio (INR) with or without bleeding.
10. Formulate an appropriate treatment plan for a patient who develops a deep vein thrombosis or pulmonary embolism, and develop a comprehensive education plan for a patient who is receiving an antithrombotic drug.

Faculty:

ACPE No:
014-999-07-019-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009